Marimed (MRMD) Operating Leases (2019 - 2026)

Marimed (MRMD) has 8 years of Operating Leases data on file, last reported at $8.4 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $8.4 million, up 15.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.4 million (up 15.34% YoY), and the FY2025 annual result was $6.6 million, down 12.36% from the prior year.
• Operating Leases improved to $8.4 million in Q1 2026 per MRMD's latest filing, from $6.6 million in the prior quarter.
• Over five years, Operating Leases peaked at $10.5 million in Q2 2023 and troughed at $4.2 million in Q4 2022.
• A 5-year average of $7.8 million and a median of $8.4 million in 2026 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2023 and 2025: Operating Leases surged 136.63% in 2023, then decreased 29.98% in 2025.
• A 5-year view of Operating Leases shows it stood at $4.2 million in 2022, then surged by 102.61% to $8.5 million in 2023, then declined by 10.72% to $7.5 million in 2024, then dropped by 12.36% to $6.6 million in 2025, then advanced by 26.74% to $8.4 million in 2026.
• Business Quant data shows MRMD's Operating Leases at $8.4 million in Q1 2026, $6.6 million in Q4 2025, and $6.8 million in Q3 2025.